• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: February 14, 2025

Key Takeaways

  • Dermatologists should be aware of potential 2025 tax law changes, including expiring TCJA provisions and new deduction policies.
  • Bimekizumab shows long-term efficacy in hidradenitis suppurativa, with over 85% of patients maintaining response and reduced draining tunnels.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters

Potential 2025 Tax Law Changes: What Dermatologists Should Know

Key 2025 tax law changes for dermatologists include expiring TCJA provisions, potential rate adjustments, and new deduction policies under Trump.

How Well Revolution Combines In-Person Care with Telehealth

Michael Rubio, PA-C talks with Renata Block, MMS, PA-C, about his virtual care platform and how it can expand access to care.

New Data on Bimekizumab’s Long-term HS Efficacy

Bimekizumab demonstrated long-term effectiveness in patients with HS, with over 85% maintaining response and reduced draining tunnels.

Tailoring Atopic Dermatitis Treatment to Meet Patient Needs

Adelaide A. Hebert, MD, FAAD, stressed the importance of educating patients, setting realistic expectations, and ensuring they adhere to AD treatment plans.

Nektar's Jonathan Zalevsky, PhD, Dives Into Rezpegaldesleukin Fast Track Designation for Atopic Dermatitis

Zalevsky shares insights into the implications of the designation and what it may mean for Rezpeg's development timeline.

Bridging Dermatology and Psychological Support

A global review found that skin condition advocacy groups offer diverse mental health resources, but accessibility gaps persist worldwide.

Related Videos
infectious disease
© 2025 MJH Life Sciences

All rights reserved.